Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Exicure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Exicure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Exicure Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Exicure Secures Venture Funding 12
Exicure Raises USD14.8 Million Financing 13
AuraSense Therapeutics Raises USD4.4 Million in Extended Series C Financing 14
AuraSense Therapeutics Raises USD13.6 Million in Series C Financing 15
AuraSense Therapeutics Raises Funds Through Extended Series B Financing 16
Private Equity 17
Exicure to Raise USD22 Million in Private Placement of Shares 17
Partnerships 19
Exicure Enters into Agreement with Ohio State University 19
Merger 20
Exicure and Max-1 Acquisition Merges in Reverse Merger Transaction 20
Licensing Agreements 21
Purdue Pharma Enters into Licensing Agreement with Exicure 21
Exicure Enters into Licensing Agreement with Northwestern University 22
Exicure Enters into Licensing Agreement with Northwestern University for SNA Technology 23
Equity Offering 24
Exicure Plans to Raise up to USD119.1 Million in Private Placement of Shares 24
Exicure Raises Additional USD11.2 Million in Private Placement of Shares 25
Exicure Raises USD20 Million in Private Placement 26
Exicure Inc – Key Competitors 27
Exicure Inc – Key Employees 28
Exicure Inc – Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
Financial Announcements 30
Aug 06, 2018: Exicure provides update on corporate progress and second quarter 2018 financial results 30
May 15, 2018: Exicure Announces First Quarter 2018 Financial Results 32
Mar 09, 2018: Exicure Reports Full Year 2017 Financial Results And Corporate Progress 34
Nov 14, 2017: Exicure Reports Third Quarter 2017 Financial Results and Provides Business Update 36
Corporate Communications 38
Apr 20, 2018: Exicure Appoints Matthias Schroff As Chief Operating Officer 38
Clinical Trials 39
Oct 02, 2018: Exicure presents first data demonstrating both oral Delivery and liver Delivery of Spherical Nucleic Acid constructs in animal models 39
Jun 14, 2018: Exicure to Present Data at the Cure Spinal Muscular Atrophy Annual Conference in Dallas 40
Other Significant Developments 41
May 23, 2018: Exicure To Begin Trading on United States OTCQB Under the Symbol “XCUR” 41
May 27, 2017: Investors flock to exicure s IPO – Luye Pharma s strategy of investment in novel biopharmaceuticals receives optimistic outlook 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
Exicure Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Exicure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Exicure Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Exicure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Exicure Secures Venture Funding 12
Exicure Raises USD14.8 Million Financing 13
AuraSense Therapeutics Raises USD4.4 Million in Extended Series C Financing 14
AuraSense Therapeutics Raises USD13.6 Million in Series C Financing 15
AuraSense Therapeutics Raises Funds Through Extended Series B Financing 16
Exicure to Raise USD22 Million in Private Placement of Shares 17
Exicure Enters into Agreement with Ohio State University 19
Exicure and Max-1 Acquisition Merges in Reverse Merger Transaction 20
Purdue Pharma Enters into Licensing Agreement with Exicure 21
Exicure Enters into Licensing Agreement with Northwestern University 22
Exicure Enters into Licensing Agreement with Northwestern University for SNA Technology 23
Exicure Plans to Raise up to USD119.1 Million in Private Placement of Shares 24
Exicure Raises Additional USD11.2 Million in Private Placement of Shares 25
Exicure Raises USD20 Million in Private Placement 26
Exicure Inc, Key Competitors 27
Exicure Inc, Key Employees 28
List of Figures
Exicure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Exicure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Exicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9